Lakewood-Amedex Biotherapeutics Inc.
Organization details
- Legal name
- Lakewood-Amedex Biotherapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- University Park
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LABT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002079272
- EIN
- 20-5274304
Board of directors
-
Joseph Edward Tucker · DirectorSince 2026
-
Kelvin Cooper · Director · Chief Executive OfficerSince 2026
-
Leonard James DeRoma · DirectorSince 2026
Chief executives
Director election results
Annual meeting of September 22, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
74.0%
-
76.8%
-
76.9%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Enveric Biosciences Inc. Same sectorvia Joseph Edward Tucker
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Lakewood-Amedex Biotherapeutics Inc.
Who is the CEO of Lakewood-Amedex Biotherapeutics Inc.?
Kelvin Cooper has been Lakewood-Amedex Biotherapeutics Inc.'s Chief Executive Officer since April 2026.
How many directors are on Lakewood-Amedex Biotherapeutics Inc.'s board?
Lakewood-Amedex Biotherapeutics Inc.'s board has 3 directors: Joseph Edward Tucker, Kelvin Cooper and Leonard James DeRoma.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="lakewood-amedex-biotherapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.